Related Experiment Videos
The interval between flexible sigmoidoscopy screening examinations can be expanded beyond five years.
M Yoshinaga1, R Watabe, J Yanagisawa
1Department of Internal Medicine, Fukuoka Teishin Hospital, 2-6-11 Yakuin, Fukuoka 810-8798, Japan. m-yoshi@winter.try-net.or.jp
Hepato-Gastroenterology
|May 31, 2001
Summary
Flexible sigmoidoscopy screening intervals may be extended beyond five years for average-risk individuals with negative initial results. This colorectal cancer screening method showed similar neoplasm incidence across extended intervals.
Area of Science:
- Gastroenterology
- Oncology
- Preventive Medicine
Background:
- Colorectal cancer screening is crucial for early detection.
- Current guidelines recommend flexible sigmoidoscopy every 5 years for average-risk individuals aged 50+.
- The optimal screening interval requires further investigation.
Purpose of the Study:
- To evaluate the feasibility of extending the flexible sigmoidoscopy screening interval beyond 5 years.
- To compare neoplasm incidence in asymptomatic average-risk individuals with varying screening intervals.
Main Methods:
- 192 asymptomatic average-risk subjects aged 50+ with initial negative flexible sigmoidoscopy were studied.
- Participants were divided into three groups based on screening intervals: 3-5 years, 5-6 years, and 6-8 years.
- Neoplasm incidence was compared across the groups.
Main Results:
- Neoplasm incidence was similar across all three screening interval groups (11.5%, 7.3%, and 12.2%).
- All detected adenomas were small (<10 mm) and lacked high-grade dysplasia or villous components.
- No colorectal cancers were detected in any group.
Conclusions:
- The findings suggest that screening flexible sigmoidoscopy intervals can potentially be extended beyond 5 years.
- This extension may be appropriate for individuals with negative initial screening results.
- Further research is warranted to confirm these findings and establish definitive guidelines.